Ablating l-fabp in SCP-2/SCP-x null mice impairs bile acid metabolism and biliary hdl-cholesterol secretion

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 307, Issue 11, 2014, Pages G1130-G1143

  Martin, Gregory G ^a   Atshaves, Barbara P ^b   Landrock, Kerstin K ^c   Landrock, Danilo ^c   Storey, Stephen M ^a   Howles, Philip N ^d   Kier, Ann B ^c   Schroeder, Friedhelm ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Michigan State University   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Bile acid; Cholesterol; Fatty acid binding protein; Gene ablation; Mouse

Indexed keywords

BILE ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; FATTY ACID BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOLIPID; STEROL CARRIER PROTEIN; STEROL CARRIER PROTEIN 2; STEROL CARRIER PROTEIN X; UNCLASSIFIED DRUG; CARRIER PROTEIN; CHOLESTEROL; FABP1 PROTEIN, MOUSE; STEROL CARRIER PROTEINS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; BILE ACID BLOOD LEVEL; BILE ACID METABOLISM; BILE ACID SYNTHESIS; BILE SECRETION; BILIARY EXCRETION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CHOLESTEROL LIVER LEVEL; HYDROPHOBICITY; LIPID ABSORPTION; MALE; MOUSE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; SECRETION (PROCESS); SOLUBILITY; UPREGULATION; ANIMAL; BILE; C57BL MOUSE; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM; PHYSIOLOGY;

ANIMALS; BILE; BILE ACIDS AND SALTS; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL, HDL; FATTY ACID-BINDING PROTEINS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOLIPIDS;

EID: 84913601790     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00209.2014     Document Type: Article

References (91)

1. Agellon LB, Torchia EC. Intracellular transport of bile acids. Biochim Biophys Acta1486: 198-209, 2000.
2. Amigo L, Zanlungo S, Miquel JF, Glick JM, Hyogo H, Cohen DE, Rigotti A, Nervi F. Hepatic overexpression of sterol carrier protein-2 inhibits VLDL production and reciprocally enhances biliary lipid secretion. J Lipid Res44: 399-407, 2003.
3. Atshaves BP, Martin GG, Hostetler HA, McIntosh AL, Kier AB, Schroeder F. Liver fatty acid binding protein (L-FABP) and dietary obesity. J Nutr Biochem21: 1015-1032, 2010.
4. Atshaves BP, McIntosh AL, Lyuksyutova OI, Zipfel WR, Webb WW, Schroeder F. Liver fatty acid binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes. J Biol Chem279: 30954-30965, 2004.
5. Atshaves BP, McIntosh AL, Payne HR, Gallegos AM, Landrock K, Maeda N, Kier AB, Schroeder F. Sterol carrier protein-2/sterol carrier protein-x gene ablation alters lipid raft domains in primary cultured mouse hepatocytes. J Lipid Res48: 2193-2211, 2007.
6. Atshaves BP, Payne HR, McIntosh AL, Tichy SE, Russell D, Kier AB, Schroeder F. Sexually dimorphic metabolism of branched chain lipids in C57BL/6J mice. J Lipid Res45: 812-830, 2004.
7. Atshaves BP, Starodub O, McIntosh AL, Roths JB, Kier AB, Schroeder F. Sterol carrier protein-2 alters HDL-mediated cholesterol efflux. J Biol Chem275: 36852-36861, 2000.
8. Bordewick U, Heese M, Borchers T, Robenek H, Spener F. Compart-mentation of hepatic fatty-acid-binding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis. Biol Chem Hoppe Seyler370: 229-238, 1989.
9. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res19: 945-955, 1978.
10. Cherradi N, Rossier MF, Vallotton MB, Timberg R, Friedberg I, Orly J, Wang XJ, Stocco DM, Capponi AM. Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome P450scc and 3 fj-hydroxysteroid dehydrogenase isomer-ase enzymes) upon stimulation by intracellular calcium in adrenal glo-merulosa cells. J Biol Chem272: 7899-7907, 1997.
11. Cohen DE. Hepatocellular transport and secretion of biliary lipids. Curr Opin Lipidol10: 295-302, 1999.
12. Colles SM, Woodford JK, Moncecchi D, Myers-Payne SC, McLean LR, Billheimer JT, Schroeder F. Cholesterol interactions with recombinant human sterol carrier protein-2. Lipids30: 795-804, 1995.
13. Di Pietro SM, Santome JA. Isolation, characterization, and binding properties of two rat liver fatty acid binding protein isoforms. Biochim Biophys Acta1478: 186-200, 2000.
14. Dietrich A, Dieminger W, Fuchte K, Stoll GH, Schlitz E, Gerok W, Kurz G. Functional significance of interaction of hepatic FABP with sulfated and nonsulfated taurine-conjugated bile salts in rat liver. J Lipid Res36: 1745-1755, 1995.
15. Dietrich A, Dieminger W, Nelly SM, Gerok W, Kurz G. Synthesis and applicability of a photolabile 7,7-azi analog of 3-sulfated taurine-conjugated bile acids. J Lipid Res36: 1729-1744, 1995.
16. Favretto F, Assfalg M, Gallo M, Cicero DO, D’Onofrio M, Molinari H. Ligand binding promiscuity and human liver fatty acid binding protein: structural and dynamic insights from an interaction study with glyco-cholate and oleate. Chembiochem14: 1807-1819, 2013.
17. Fischer RT, Cowlen MS, Dempsey ME, Schroeder F. Fluorescence of A5,7,9(11),22-ergostatetraen-3fj-ol in micelles, sterol carrier protein complexes, and plasma membranes. Biochemistry24: 3322-3331, 1985.
18. Frikke-Schmidt R. Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population. Atherosclerosis208: 305-316, 2010.
19. Frolov A, Petrescu A, Atshaves BP, So PT, Gratton E, Serrero G, Schroeder F. High density lipoprotein mediated cholesterol uptake and targeting to lipid droplets in intact L-cell fibroblasts. J Biol Chem275: 12769-12780, 2000.
20. Frolov A, Woodford JK, Murphy EJ, Billheimer JT, Schroeder F. Spontaneous and protein-mediated sterol transfer between intracellular membranes. J Biol Chem271: 16075-16083, 1996.
21. Frolov AA, Woodford JK, Murphy EJ, Billheimer JT, Schroeder F. Fibroblast membrane sterol kinetic domains: modulation by sterol carrier protein 2 and liver fatty acid binding protein. J Lipid Res37: 1862-1874, 1996.
22. Fuchs M, Hafer A, Muench C, Kannenberg F, Teichmann S, Scheib-ner J, Stange EF, Seedorf U. Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism. J Biol Chem276: 48058–48065, 2001.
23. Gallegos AM, Atshaves BP, Storey SM, Starodub O, Petrescu AD, Huang H, McIntosh A, Martin G, Chao H, Kier AB, Schroeder F. Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Prog Lipid Res40: 498-563, 2001.
24. Guariento M, Raimondo D, Assfalg M, Zanzoni S, Pesente P, Ragona L, Tramontano A, Molinari H. Identification and functional characterization of the bile acid transport proteins in non-mammalian ileum and mammalian liver. Proteins70: 462-472, 2008.
25. Hagan RM, Worner-Gibbs J, Wilton DC. Tryptophan insertion mutagenesis of liver fatty acid binding protein. J Biol Chem280: 1782-1789, 2005.
26. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res30: 719-730, 1989.
27. Hirai A, Kino T, Tokinaga K, Tahara K, Tamura Y, Yoshida S. Regulation of sterol carrier protein 2 (SCP2) gene expression in rat peritoneal macrophages during foam cell formation. A key role for free cholesterol content. J Clin Invest94: 2215-2223, 1994.
28. Huggins KW, Camarota LM, Howles PN, Hui DY. Pancreatic triglyceride lipase deficiency minimally affects dietary fat absorption but dramatically decreases dietary cholesterol absorption in mice. J Biol Chem44: 42899–42905, 2003.
29. Ji Y, Wang N, Ramakrishnan R, Sehayek E, Huszar D, Breslow JL, Tall AR. Hepatic scavenger receptor B1 promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem274: 33398-33402, 1999.
30. Jolly CA, Chao H, Kier AB, Billheimer JT, Schroeder F. Sterol carrier protein-2 suppresses microsomal acyl CoA hydrolysis. Mol Cell Biochem205: 83-90, 2000.
31. Jolly CA, Hubbell T, Behnke WD, Schroeder F. Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation. Arch Biochem Biophys341: 112-121, 1997.
32. Jolly CA, Hubbell T, Behnke WD, Schroeder F. Fatty acid binding protein: stimulation of microsomal phosphatidic acid formation. Arch Biochem Biophys341: 112-121, 1997.
33. Jolly CA, Murphy EJ, Schroeder F. Differential influence of rat liver fatty acid binding protein isoforms on phospholipid fatty acid composition: phosphatidic acid biosynthesis and phospholipid fatty acid remodeling. Biochim Biophys Acta1390: 258-268, 1998.
34. Jolly CA, Wilton DA, Schroeder F. Microsomal fatty acyl CoA transacy-lation and hydrolysis: fatty acyl CoA species dependent modulation by liver fatty acyl CoA binding proteins. Biochim Biophys Acta1483: 185-197, 2000.
35. Kaikaus RM, Bass NM, Ockner RK. Functions of fatty acid binding proteins. Experientia46: 617-630, 1990.
36. Kannenberg F, Ellinghaus P, Assmann G, Seedorf U. Aberrant oxidation of the cholesterol side chain in bile acid synthesis of sterol carrier protein-2/sterol carrier protein-x knockout mice. J Biol Chem274: 35455-35460, 1999.
37. Kawata S, Imai Y, Inada M, Inui M, Kakimoto H, Fukuda K, Maeda Y, Tarui S. Modulation of cholesterol 7a-hydroxylase activity by nsLTP in human liver—possible altered regulation of its cytosolic level in patients with gallstones. Clin Chim Acta197: 201-208, 1991.
38. Keller GA, Scallen TJ, Clarke D, Maher PA, Krisans SK, Singer SJ. Subcellular localization of sterol carrier protein-2 in rat hepatocytes: its primary localization to peroxisomes. J Cell Biol108: 1353-1361, 1989.
39. Kriska T, Levchenko VV, Korytowski W, Atshaves BP, Schroeder F, Girotti AW. Hypersensitivity of sterol carrier protein-2 overexpressing hepatoma cells to lethal peroxidative damage induced by an exogenous cholesterol hydroperoxide. J Biol Chem281: 23643-23651, 2006.
40. Kriska T, Levchenko VV, Korytowski W, Atshaves BP, Schroeder F, Girotti AW. Intracellular dissemination of peroxidative stress. Internalization, transport, and lethal targeting of a cholesterol hydroperoxide species by sterol carrier protein-2 overexpressing hepatoma cells. J Biol Chem281: 23643-23651, 2006.
41. Kriska T, Pilat A, Schmitt JC, Girotti AW. Sterol carrier protein-2 (SCP-2) involvement in cholesterol hydroperoxide cytotoxicity as revealed by SCP-2 inhibitor effects. J Lipid Res51: 3184, 2010.
42. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev89: 147-191, 2009.
43. Li T, Chiang JY. Regulation of bile acid and cholesterol metabolism by PPARs. PPAR Res2009: 501739, 2009.
44. Martin GG, Atshaves BP, Huang H, McIntosh AL, Williams BW, Pai PJ, Russell DH, Kier AB, Schroeder F. Hepatic phenotype of liver fatty acid binding protein (L-FABP) gene ablated mice. Am J Physiol Gastro-intest Liver Physiol297: G1053-G1065, 2009.
45. Martin GG, Atshaves BP, McIntosh AL, Mackie JT, Kier AB, Schroeder F. Liver fatty acid binding protein (L-FABP) gene ablation alters liver bile acid metabolism in male mice. Biochem J391: 549-560, 2005.
46. Martin GG, Danneberg H, Kumar LS, Atshaves BP, Erol E, Bader M, Schroeder F, Binas B. Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid binding protein (L-FABP) gene. J Biol Chem278: 21429-21438, 2003.
47. Martin GG, Hostetler HA, McIntosh AL, Tichy SE, Williams BJ, Russell DH, Berg JM, Spencer TA, Ball JA, Kier AB, Schroeder F. Structure and function of the sterol carrier protein-2 (SCP-2) N-terminal pre-sequence. Biochemistry47: 5915-5934, 2008.
48. McArthur MJ, Atshaves BP, Frolov A, Foxworth WD, Kier AB, Schroeder F. Cellular uptake and intracellular trafficking of long chain fatty acids. J Lipid Res40: 1371-1383, 1999.
49. McIntosh AL, Atshaves BP, Hostetler HA, Huang H, Davis J, Ly-uksyutova OI, Landrock D, Kier AB, Schroeder F. Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator activated receptor-a activity in cultured primary hepatocytes. Arch Biochem Biophys485: 160-173, 2009.
50. Monaco HL. The liver bile acid binding proteins. Biopolymers91: 1196-1202, 2009.
51. Moncecchi DM, Murphy EJ, Prows DR, Schroeder F. Sterol carrier protein-2 expression in mouse L-cell fibroblasts alters cholesterol uptake. Biochim Biophys Acta1302: 110-116, 1996.
52. Murphy EJ. L-FABP and I-FABP expression increase NBD-stearate uptake and cytoplasmic diffusion in L-cells. Am J Physiol Gastrointest Liver Physiol275: G244-G249, 1998.
53. Murphy EJ, Schroeder F. Sterol carrier protein-2 mediated cholesterol esterification in transfected L-cell fibroblasts. Biochim Biophys Acta1345: 283-292, 1997.
54. Myers-Payne SC, Fontaine RN, Loeffler A, Pu L, Rao AM, Kier AB, Wood WG, Schroeder F. Effects of chronic ethanol consumption on sterol transfer proteins in mouse brain. J Neurochem66: 313-320, 1996.
55. Nemecz G, Schroeder F. Selective binding of cholesterol by recombinant fatty acid-binding proteins. J Biol Chem266: 17180-17186, 1991.
56. Pagano K, Tomaselli S, Zanzoni S, Assfalg M, Molinari H, Ragona L. Bile acid binding protein: a versatile host of small hydrophobic ligands for applications in the fields of MRI contrast agents and bionanomaterials. Comput Struct Biotechnol J6: e201303021, 2013.
57. Puglielli L, Rigotti A, Amigo L, Nunez L, Greco AV, Santos MJ, Nervi F. Modulation on intrahepatic cholesterol trafficking: evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transfer into bile. Biochem J317: 681-687, 1996.
58. Rajaraman G, Wang GQ, Yan J, Jiang P, Gong Y, Burczynski FJ. Role of cytosolic liver fatty acid binding protein in hepatocellular oxidative stress: effect of dexamethasone and clofibrate treatment. Mol Cell Biochem295: 27-34, 2007.
59. Ren S, Hylemon P, Marques D, Hall E, Redford K, Gil G, Pandak WM. Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis. J Lipid Res45: 2123-2131, 2004.
60. Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol16: 459-481, 2000.
61. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the HDL receptor SRB1 reveals its key role in HDL metabolism. Proc Natl Acad Sci USA94: 12610-12615, 1997.
62. Robins SJ, Fasulo JM. Delineation of a novel hepatic route for the selective transfer of unesterified sterols from high density lipoproteins to bile: studies using the perfused rat liver. Hepatology29: 1541-1548, 1999.
63. Rossi SS, Converse JL, Hofman AF. High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. J Lipid Res28: 589-595, 1987.
64. Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem72: 137-174, 2003.
65. Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orasic M, Bäckhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-fj-murich-olic acid, a naturally occurring FXR antagonist. Cell Metab17: 225-235, 2014.
66. Scapin G, Spadon P, Pengo L, Mammi M, Zanotti G, Monaco HL. Chicken liver basic fatty acid-binding protein (pI = 9.0). FEBS Lett240: 196-200, 1988.
67. Schroeder F, Jolly CA, Cho TH, Frolov AA. Fatty acid binding protein isoforms: structure and function. Chem Phys Lipids92: 1-25, 1998.
68. Seedorf U, Brysch P, Engel T, Schrage K, Assmann G. Sterol carrier protein X is peroxisomal 3-oxoacyl coenzyme A thiolase with intrinsic sterol carrier and lipid transfer activity. J Biol Chem269: 21277-21283, 1994.
69. Seedorf U, Raabe M, Ellinghaus P, Kannenberg F, Fobker M, Engel T, Denis S, Wouters F, Wirtz KW, Wanders RJ, Maeda N, Assmann G. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. Genes Dev12: 1189-1201, 1998.
70. Singer SS, Dravis D, Henkels K, Trulzsch DV. Fatty acid binding protein inhibits glycolithocholate sulfation. Biochem Int27: 373-383, 1992.
71. Stolowich NJ, Frolov A, Petrescu AD, Scott AI, Billheimer JT, Schroeder F. Holo-sterol carrier protein-2: 13C-NMR investigation of cholesterol and fatty acid binding sites. J Biol Chem274: 35425-35433, 1999.
72. Stolowich NJ, Petrescu AD, Huang H, Martin G, Scott AI, Schroeder F. Sterol carrier protein-2: structure reveals function. Cell Mol Life Sci59: 193-212, 2002.
73. Stolz A, Takikawa H, Ookhtens M, Kaplowitz N. The role of cytoplasmic proteins in hepatic bile acid transport. Annu Rev Physiol51: 161-176, 1989.
74. Storch J, Corsico B. The emerging functions and mechanisms of mammalian fatty acid binding proteins. Annu Rev Nutr28: 18.1-18.23, 2008.
75. Storey SM, Atshaves BP, McIntosh AL, Landrock KK, Martin GG, Huang H, Johnson JD, Macfarlane RD, Kier AB, Schroeder F. Effect of sterol carrier protein-2 gene ablation on HDL-mediated cholesterol efflux from primary cultured mouse hepatocytes. Am J Physiol Gastroin-test Liver Physiol299: G244-G254, 2010.
76. Storey SM, McIntosh AL, Huang H, Martin GG, Landrock KK, Landrock D, Payne HR, Kier AB, Schroeder F. Loss of intracellular lipid binding proteins differentially impacts saturated fatty acid uptake and nuclear targeting in mouse hepatocytes. Am J Physiol Gastrointest Liver Physiol303: G837–G850, 2012.
77. Storey SM, McIntosh AL, Huang H, Martin GG, Landrock KK, Landrock D, Payne HR, Kier AB, Schroeder F. Intracellular cholesterol binding proteins enhance HDL-mediated cholesterol uptake in cultured primary mouse hepatocytes. Am J Physiol Gastrointest Liver Physiol302: G824–G839, 2012.
78. Takikawa H, Kaplowitz N. Binding of bile acids, oleic acid, and organic anions by rat and human hepatic Z protein. Arch Biochem Biophys251: 385–392, 1986.
79. Thumser AE, Wilton DC. The binding of cholesterol and bile salts to recombinant rat liver fatty acid-binding protein. Biochem J320: 729–733, 1996.
80. Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev83: 633–671, 2003.
81. Van Amerongen A, Demel RA, Westerman J, Wirtz KW. Transfer of cholesterol and oxysterol derivatives by nonspecific lipid transfer protein (SCP-2). Biochim Biophys Acta1004: 36–46, 1989.
82. van der Velden LM, Golynskiy MV, Bijsmans IT, van Mil SW, Klomp LW, Merkx M, van de Graaf SF. Monitoring bile acid transport in single living cells using a genetically encoded Forster resonance energy transfer sensor. Hepatology57: 740–752, 2013.
83. Van Eck M, Twisk J, Hoekstra M, Van Rij BT, Van der Lans CA, Bos IS, Kruijt JK, Kuipers F, Van Berkel TJ. Differential effects of SRB1 deficiency on lipid metabolism in cells of the arterial wall and in the liver. J Biol Chem278: 23699–23705, 2003.
84. Vila A, Levchenko VV, Korytowski W, Girotti AW. Sterol carrier protein-2 facilitated intermembrane transfer of cholesterol- and phospho-lipid-derived hydroperoxides. Biochemistry43: 12592–12605, 2004.
85. Wang G, Gong Y, Anderson J, Sun D, Minuk G, Robertes MS, Burczynski FJ. Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. Hepatology42: 871–879, 2005.
86. Wang G, Shen H, Rajaraman G, Roberts MS, Gong Y, Jiang P, Burczynski FJ. Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats. Eur J Pharmacol560: 61–68, 2007.
87. Weisiger RA. Cytosolic fatty acid binding proteins catalyze two distinct steps in intracellular transport of their ligands. Mol Cell Biochem239: 35–42, 2005.
88. Xie Y, Newberry EP, Kennedy SM, Luo J, Davidson NO. Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice. J Lipid Res50: 977–987, 2009.
89. Yan J, Gong Y, She YM, Wang G, Roberts MS, Burczynski FJ. Molecular mechanism of recombinant liver fatty acid binding protein’s antioxidant activity. J Lipid Res50: 2445–2454, 2009.
90. Yan J, Gong Y, She YM, Wang G, Robertes MS, Burczynski FJ. Molecular mechanism of recombinant L-FABP’s antioxidant activity. J Lipid Res50: 2445–2454, 2010.
91. Zanlungo S, Rigotti A, Nervi F. Hepatic cholesterol transport from plasma into bile: implications for gallstone disease. Curr Opin Lipidol15: 279–286, 2004.